NCT00003430
- Conditions
- Head and Neck Cancer, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, +17 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
Clinical trial condition
Pharyngeal Neoplasms
Explore clinical trials studying Pharyngeal Neoplasms. Study availability and eligibility vary by location and protocol.
734 public trials
231 recruiting studies
Pharyngeal Neoplasms trial results
NCT00005952
- Conditions
- Adnexal Diseases, Astrocytoma, Brain Diseases, +71 more
- Locations
-
- Duke Comprehensive Cancer Center Durham, North Carolina, United States
Completed
Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas
NCT00101270
- Conditions
- Astrocytoma, Burkitt Lymphoma, Childhood Burkitt Lymphoma, +115 more
- Locations
-
- COG Phase I Consortium Arcadia, California, United States
NCT00091182
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +99 more
- Locations
-
- Children's Oncology Group Arcadia, California, United States
NCT00045006
- Conditions
- Adenocarcinoma, Adnexal Diseases, Blood Protein Disorders, +110 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
Completed
Computer-Assisted Scheduling of Nicotine Inhaler Use in Participants Who Plan to Stop Smoking
NCT00021138
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +33 more
- Locations
-
- Personal Improvement Computer Systems, Incorporated Reston, Virginia, United States
NCT01379872
- Conditions
- Anal Cancer, Anus Diseases, Anus Neoplasms, +30 more
- Locations
-
- Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
- Liverpool Hospital Liverpool, New South Wales, Australia
- Calvary Mater Newcastle Newcastle, New South Wales, Australia
- Prince of Wales Hospital Randwick, New South Wales, Australia
NCT00002964
- Conditions
- Head and Neck Cancer, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, +14 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Completed
Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer
NCT00305734
- Conditions
- Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms, +9 more
- Locations
-
- Southwest Oncology Group San Antonio, Texas, United States
NCT00064103
- Conditions
- Head and Neck Neoplasms, Lip and Oral Cavity Cancer, Mouth Diseases, +15 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States